959
NYSE & Nasdaq companies trading below book value, Altuva proprietary screen
$5M
Proposed MVLS minimum, immediate suspension, no cure period, March 2026
The architecture of the old system was built on delay. A company falling below $1.00 per share received a deficiency notice and an automatic 180-day compliance period. Then another 180 days. Then an appeal that kept the stock trading on-exchange.
Nasdaq has closed each of those doors in sequence. What remains is a countdown with a known end date.
121
$5M
The process has accelerated materially over the past eighteen months, and it follows a consistent logic: close each escape route in sequence. What reads as a series of technical rule amendments is, in aggregate, the construction of a compliance framework with no exits.
The old system was deliberately forgiving. A company that fell below the $1.00 minimum bid price for 30 consecutive business days received a deficiency notice and an automatic 180-day compliance period. If it failed to recover, a second 180-day period was available to Nasdaq Capital Market companies. If Nasdaq then moved to delist, the company could appeal and, critically, the appeal automatically stayed the delisting, allowing the stock to continue trading on-exchange while the process ran. In practice, a determined management team could extend the compliance clock by 18 months or more while executing reverse stock splits and repeat appeals.
Nasdaq has closed each of those doors in sequence.
Regulatory timeline
Nasdaq listing standard amendments, 2021–2026
Sept 2021
Excessive reverse split restriction
Companies with cumulative reverse split ratio of 250:1 or more over two years subject to immediate delisting, with no compliance period.
Nov 2023
Enhanced disclosure requirements
Additional public disclosure obligations for reverse splits; trading halt procedures introduced.
Nov 2023
Enhanced disclosure requirements
Additional public disclosure obligations for reverse splits; trading halt procedures introduced.
Oct 2024
Rule 5810(c)(3)(A) amended
Reverse split that triggers any additional listing deficiency does not cure the original bid price deficiency. Both must be resolved simultaneously within the original compliance period.
Live
Jan 2025
Immediate delisting post-reverse-split & appeal stay eliminated
Company that falls below $1.00 within one year of a reverse split receives an immediate delisting determination, with no compliance period. After 360 days of non-compliance: automatic trading suspension regardless of appeal status. Appeal no longer stays delisting.
Live
Jan 19, 2026
Low Price Rule ($0.10) operative
Closing bid at or below $0.10 for 10 consecutive business days triggers immediate delisting determination, regardless of any existing compliance period. Operates independently of the $1.00 rule.
Live
~Mar 2026
$5M MVLS rule, pending SEC approval
Market value of listed securities below $5 million for 30 consecutive business days triggers immediate trading suspension and delisting. No cure period. Appeal limited to factual errors only.
Pending
Each amendment has been framed as a targeted investor protection measure. Collectively, they have eliminated the strategy that hundreds of small-cap companies relied upon: buy time, execute a reverse split, and appeal if needed. That strategy no longer works.
The Low Price Rule, effective January 19, 2026, is the sharpest recent development. It does not require a company to be in a compliance period. It does not require a prior deficiency notice. A company can be in good standing on the $1.00 rule and still receive an immediate delisting determination if its stock closes at or below ten cents for ten consecutive business days. For companies in the sub-$5 million market cap range, where stock prices and market values move together, the two rules increasingly operate as a combined net.
Key Rule Citations
Nasdaq Listing Rule 5810(c)(3)(A), amended Oct 2024 & Jan 2025
Nasdaq Listing Rules 5450(a)(3) & 5550(a)(6), proposed Jan 2026
Low Price Rule: Listing Rule 5810(c)(3), effective Jan 19, 2026
NYSE Section 802.01C, parallel amendments, Jan 2025
Enforcement
360
Maximum days before automatic trading suspension, down from 18+ months under prior rules
Sources
Goodwin Law, Feb 2025
Norton Rose Fulbright, Jan 2026
Dechert, Jan 2026
Clark Hill, Feb 2026
Federal Register, Jan 2025
Nasdaq's position is not unreasonable, stated plainly. Companies that have repeatedly cycled through reverse splits, price recovery, and renewed deficiency have demonstrated, as a statistical matter, that they are unlikely to achieve durable compliance. The exchange's own data, cited in its SEC rule filings, supports this. Patterns of haphazard reverse splits indicate deeper operational issues which are likely to render the company unsuitable for continued listing.
The elimination of the appeal stay also addresses a genuine structural problem. Companies with no realistic recovery path were using the appeals process as a mechanism to remain listed for extended periods, to the detriment of retail investors who purchased shares without understanding the delisting risk. The Low Price Rule reflects Nasdaq's documented observation that companies whose shares trade in single-digit cent territory exhibit deep financial or operational distress that is generally not temporary.
The Proportionality Problem
The implication is that the structural discount in sub-$300 million public companies will not be corrected from within the public market. It will be corrected, company by company, by transactions (acquisitions, going-private deals, or partnership structures) that remove these companies from the public market and unlock the value that passive investing has indefinitely deferred.
Altuva was built to be the counterparty for precisely this transaction: a listed, board-friendly platform that partners with management to unlock value that the market has structurally decided not to price.
The passive revolution has been enormously beneficial for the investors who own large cap index funds. For the companies that sit below the index threshold, it has produced something different: a permanent underclass of public companies, generating cash, operating profitably, and carrying fundamental value that the market, by structural design, has stopped paying attention to.
That persistent inattention is where Altuva operates.
Old vs. New
6 weeks
Decision window under proposed $5M MVLS rule, down from 12–18 months under prior framework
Exchange Position
Repeated reverse splits indicate financial instability unsuitable for listing
Retail investors harmed by extended non-compliant trading
Sub-$0.10 stocks reflect non-temporary operational distress
Sub-$5M market cap unlikely to achieve durable compliance
Altuva's proprietary screen of all NYSE and Nasdaq-listed equities identified approximately 959 companies currently trading below book value, businesses where the gap between market price and fundamental asset value is structural rather than cyclical. These are not companies awaiting re-rating. They are companies the market has, in the language of our first article in this series, structurally stopped paying attention to.
That universe now sits inside a regulatory framework with an active and tightening compliance calendar. Not all 959 are in deficiency. But every company in that universe that crosses the $5M MVLS threshold, or falls below $1.00, or touches $0.10, now faces a compliance clock that compresses the decision window to weeks rather than months.
The Exposed Universe
NYSE & Nasdaq companies, Altuva proprietary screen
The conventional options available to a board in this position have all become more difficult simultaneously. The new rules did not create a vacuum. They created a mismatch between the speed at which the compliance clock runs and the speed at which conventional processes move.
Reverse stock split
Self-defeating for companies that have previously used one. Falls below $1.00 within twelve months of any split now triggers immediate delisting determination with no compliance period available.
Restricted
Going-private transaction
Requires SEC Rule 13e-3 disclosures, Schedule 13E-3 filing, fairness opinion, and minority shareholder protections. Total process typically runs 4–6 months. Incompatible with a 30-business-day MVLS window.
Constrained
Strategic acquisition
Strategic acquirers do not engage at sub-$10M market capitalisations. Investment banks will not take mandates. The compliance deadline does not allow sufficient time for a staged sale process.
Unavailable
Delisting with asset distribution
Destroys the liquidity premium on the listed vehicle and the optionality that a structured transaction could have preserved. Shareholders receive distressed value rather than partnership value.
Value destructive
Partnership with a listed acquisition platform
A listed acquirer using its own shares as consideration can move at transaction speed without debt financing, without an investment bank mandate, and without the multi-month timeline of a conventional process. The board receives a credible counterparty; shareholders receive immediate value and ongoing participation.
Viable
The Nasdaq rules have created something that did not previously exist in the small-cap market: a regulatory forcing function with a known deadline that applies to a quantifiable universe of companies. The boards that act before that clock starts are in a structurally different negotiating position than those who act after it.
Altuva is the counterparty this universe needs: one that can move at the speed of a regulatory deadline, does not require debt financing, and can offer shareholders immediate value without requiring the board to run a multi-month investment bank process. A board facing the $5M MVLS rule, if approved, has 30 consecutive business days before trading is suspended. That is not a compliance problem. That is a transaction deadline.
The Altuva Proposition
Listed Nasdaq platform, shares as consideration, no debt financing required
Board-friendly structure, confidential, tailored to each company's goals
Transaction speed compatible with regulatory deadlines
Shareholders receive liquid Nasdaq equity and ongoing participation
Tax-efficient: share-for-share exchanges structured under IRC Section 368
Proposed Rule Timeline
30
Business days below $5M before trading suspended under proposed MVLS rule, approximately six weeks
The Rule in Numbers
Filed with SEC: January 13, 2026
Published Federal Register: January 29, 2026
Practitioners preparing for effectiveness: ~March 16, 2026
Cure period: None
Appeal rights: Factual error only
Where Altuva
Operates
The 959 companies trading below book value are not all in active deficiency. But every company in that universe that crosses a compliance threshold now faces a calendar that the old system absorbed and the new system does not.
The window between a deficiency notice and a forced outcome has narrowed from 18 months to weeks. The companies that recognise this before the clock starts are the ones with options.
The regulatory pressure Nasdaq is applying is, in effect, forcing a decision that many boards have been deferring. The exchange's stated rationale is investor protection, preventing retail shareholders from holding shares in companies with no credible path to compliance. The practical effect is a structured deadline that separates boards who act from boards who do not.
Altuva was built for this gap. A listed, board-friendly platform that partners with management to unlock value and restore it to shareholders through tailored capital solutions, at the speed a regulatory deadline requires, and at the size that no conventional counterparty will service.
The window is open. The compliance calendar is running. The boards that engage before the clock starts will find a structurally different transaction than those who engage after it. That distinction is where Altuva operates.
Sources & Footnotes
Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A) (prior to amendments). Standard 180-day compliance periods described in Buchanan Ingersoll & Rooney, "New NYSE and Nasdaq Listing Requirements," February 2025.
Goodwin Law, "New Nasdaq and NYSE Delisting Rules Restrict Use of Reverse Stock Splits," February 2025. SEC approval of amended Rule 5810(c)(3)(A), January 17, 2025. goodwinlaw.com/en/insights/blogs/2025/02/new-nasdaq-and-nyse-delisting-rules-restrict-use-of-reverse-stock-splits
Federal Register, Release No. 34-102398, "Order Granting Approval of Proposed Rule Change to Modify Application of Minimum Bid Price Compliance Periods," January 23, 2025. federalregister.gov/documents/2025/01/23/2025-01621/
Norton Rose Fulbright, "Nasdaq Rule Update," January 16, 2026. Low Price Rule ($0.10 for 10 consecutive business days) operative January 19, 2026. SEC approved December 5, 2025. nortonrosefulbright.com/en/knowledge/publications/3fe61375/nasdaq-rule-update
Dechert LLP, "Nasdaq Proposes US$5 Million Market Value Continued Listing Requirement," January 22, 2026. Proposal filed January 13, 2026. dechert.com/knowledge/onpoint/2026/1/nasdaq-proposes-us-5-million-market-value-continued-listing-requ.html
Clark Hill PLC, "Nasdaq's Proposed $5 Million MVLS Rule and NYSE American's Proposed Listing Standard: A Structural Shift for Small-Cap Issuers," February 27, 2026. Practitioners preparing for possible effectiveness March 16, 2026. clarkhill.com/news-events/news/nasdaqs-proposed-5-million-mvls-rule
Corporate & Securities Law Blog, "Navigating Nasdaq and NYSE: Essential Insights for Companies," April 29, 2025. As of April 21, 2025: 158 companies had received bid price deficiency notices from Nasdaq; 121 total delistings from Nasdaq and NYSE year to date. corporatesecuritieslawblog.com/2025/04/
Altuva Group, proprietary screen of all NYSE and Nasdaq-listed equities. Methodology: closing price divided by book value per share below 1.0x, all listed equities. Internal analysis; not independently verified. Date of screen to be confirmed by Altuva Group.
Category Differentiation Priced; AI Monetisation Validated